Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol
Conclusions Resveratrol is a promising agent for the treatment of hyperuricemia-related NAFLD through activating SIRT1 pathways.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Alcoholism | Diets | Drugs & Pharmacology | Fatty Liver Disease (FLD) | High Fat | Insulin | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Pathology | Potassium | Study | Urology & Nephrology